单倍体相合造血干细胞移植后的CD4 + T细胞同种异体反应性 - Suppr

CD4+ T-cell alloreactivity after haploidentical hematopoietic stem cell transplantation.

作者信息

Kalin Burak, Metafuni Elisabetta, Ter Borg Mariëtte, Wijers Rebecca, Braakman Eric, Lamers Cor H J, Bacigalupo Andrea, Cornelissen Jan J

机构信息

Erasmus University Medical Center, Department of Hematology, Rotterdam, the Netherlands.

Istituto di Ematologia, Fondazione Policlinico Universitario A Gemelli IRCCS, Roma, Italy.

出版信息

Haematologica. 2021 Feb 1;106(2):585-588. doi: 10.3324/haematol.2019.244152.

DOI:10.3324/haematol.2019.244152

PMID:32165488

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7849555/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c467/7849555/b3462ffd0595/106585.fig1.jpg

相似文献

CD4+ T-cell alloreactivity after haploidentical hematopoietic stem cell transplantation.

Haematologica. 2021 Feb 1;106(2):585-588. doi: 10.3324/haematol.2019.244152.

Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.

Dan Med Bull. 2007 May;54(2):112-39.

Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Haematologica. 2017 Nov;102(11):1810-1822. doi: 10.3324/haematol.2017.176107. Epub 2017 Sep 7.

CD8CD161 T cells are associated with acute graft-versus-host disease after haploidentical hematopoietic stem cell transplantation.

Bone Marrow Transplant. 2020 Aug;55(8):1652-1654. doi: 10.1038/s41409-020-0842-4. Epub 2020 Mar 2.

Can planned CD34+ stem cell boost prevent poor graft function after peripheral blood haploidentical hematopoietic transplantation?

Leuk Lymphoma. 2021 Mar;62(3):749-751. doi: 10.1080/10428194.2020.1839657. Epub 2020 Nov 2.

Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation.

Ann Hematol. 2017 May;96(5):817-827. doi: 10.1007/s00277-017-2941-x. Epub 2017 Feb 28.

Differences in Aspergillus-specific immune recovery between T-cell-replete and T-cell-depleted hematopoietic transplants.

Eur J Haematol. 2015 Dec;95(6):551-7. doi: 10.1111/ejh.12531. Epub 2015 Mar 16.

Does haploidentical transplantation in children with primary immunodeficiencies have the potential to exploit donor NK cell alloreactivity?

Bone Marrow Transplant. 2004 Dec;34(11):945-7. doi: 10.1038/sj.bmt.1704663.

Donor-derived CD4/CCR7 T-cell impact on acute GVHD incidence following haplo-HCT after reduced intensity conditioning and posttransplant cyclophosphamide.

Bone Marrow Transplant. 2019 Oct;54(10):1686-1693. doi: 10.1038/s41409-019-0511-7. Epub 2019 Mar 19.

Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation.

Haematologica. 2021 Jan 1;106(1):269-274. doi: 10.3324/haematol.2019.227371.

引用本文的文献

Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.

Biol Blood Marrow Transplant. 2020 Oct;26(10):1930-1936. doi: 10.1016/j.bbmt.2020.06.029. Epub 2020 Jul 7.

本文引用的文献

Double Umbilical Cord Blood Transplantation in High-Risk Hematological Patients: A Phase II Study Focusing on the Mechanism of Graft Predominance.

Hemasphere. 2019 Aug 9;3(4):e285. doi: 10.1097/HS9.0000000000000285. eCollection 2019 Oct.

How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide.

Blood. 2019 Nov 21;134(21):1802-1810. doi: 10.1182/blood.2019001323.

Immune reconstitution after T-cell replete HLA-haploidentical transplantation.

Semin Hematol. 2019 Jul;56(3):221-226. doi: 10.1053/j.seminhematol.2019.03.005. Epub 2019 Mar 26.

NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.

Blood. 2018 Jan 11;131(2):247-262. doi: 10.1182/blood-2017-05-780668. Epub 2017 Oct 6.

Dendritic Cell Recovery Impacts Outcomes after Umbilical Cord Blood and Sibling Donor Transplantation for Hematologic Malignancies.

Biol Blood Marrow Transplant. 2017 Nov;23(11):1925-1931. doi: 10.1016/j.bbmt.2017.07.008. Epub 2017 Jul 17.

Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide.

J Clin Oncol. 2017 Sep 10;35(26):3002-3009. doi: 10.1200/JCO.2017.72.8428. Epub 2017 Jun 23.

CD4+ T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation.

Blood. 2016 Oct 27;128(17):2165-2174. doi: 10.1182/blood-2016-06-718619. Epub 2016 Aug 16.

Early evaluation of immune reconstitution following allogeneic CD3/CD19-depleted grafts from alternative donors in childhood acute leukemia.

Bone Marrow Transplant. 2012 Nov;47(11):1419-27. doi: 10.1038/bmt.2012.43. Epub 2012 Mar 12.

High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation.

Immunol Res. 2010 Jul;47(1-3):65-77. doi: 10.1007/s12026-009-8139-0.

Hematopoietic stem-cell transplantation.

N Engl J Med. 2006 Apr 27;354(17):1813-26. doi: 10.1056/NEJMra052638.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

CD4+ T-cell alloreactivity after haploidentical hematopoietic stem cell transplantation.

作者信息

Kalin Burak, Metafuni Elisabetta, Ter Borg Mariëtte, Wijers Rebecca, Braakman Eric, Lamers Cor H J, Bacigalupo Andrea, Cornelissen Jan J

机构信息

Erasmus University Medical Center, Department of Hematology, Rotterdam, the Netherlands.

Istituto di Ematologia, Fondazione Policlinico Universitario A Gemelli IRCCS, Roma, Italy.

出版信息

Haematologica. 2021 Feb 1;106(2):585-588. doi: 10.3324/haematol.2019.244152.

DOI:10.3324/haematol.2019.244152

PMID:32165488

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7849555/

Abstract

摘要

相似文献

CD4+ T-cell alloreactivity after haploidentical hematopoietic stem cell transplantation.

Haematologica. 2021 Feb 1;106(2):585-588. doi: 10.3324/haematol.2019.244152.

Dan Med Bull. 2007 May;54(2):112-39.

Haematologica. 2017 Nov;102(11):1810-1822. doi: 10.3324/haematol.2017.176107. Epub 2017 Sep 7.

CD8CD161 T cells are associated with acute graft-versus-host disease after haploidentical hematopoietic stem cell transplantation.

Bone Marrow Transplant. 2020 Aug;55(8):1652-1654. doi: 10.1038/s41409-020-0842-4. Epub 2020 Mar 2.

Can planned CD34+ stem cell boost prevent poor graft function after peripheral blood haploidentical hematopoietic transplantation?

Leuk Lymphoma. 2021 Mar;62(3):749-751. doi: 10.1080/10428194.2020.1839657. Epub 2020 Nov 2.

Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation.

Ann Hematol. 2017 May;96(5):817-827. doi: 10.1007/s00277-017-2941-x. Epub 2017 Feb 28.

Differences in Aspergillus-specific immune recovery between T-cell-replete and T-cell-depleted hematopoietic transplants.

Eur J Haematol. 2015 Dec;95(6):551-7. doi: 10.1111/ejh.12531. Epub 2015 Mar 16.

Does haploidentical transplantation in children with primary immunodeficiencies have the potential to exploit donor NK cell alloreactivity?

Bone Marrow Transplant. 2004 Dec;34(11):945-7. doi: 10.1038/sj.bmt.1704663.

Donor-derived CD4/CCR7 T-cell impact on acute GVHD incidence following haplo-HCT after reduced intensity conditioning and posttransplant cyclophosphamide.

Bone Marrow Transplant. 2019 Oct;54(10):1686-1693. doi: 10.1038/s41409-019-0511-7. Epub 2019 Mar 19.

Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation.

Haematologica. 2021 Jan 1;106(1):269-274. doi: 10.3324/haematol.2019.227371.

引用本文的文献

Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.

Biol Blood Marrow Transplant. 2020 Oct;26(10):1930-1936. doi: 10.1016/j.bbmt.2020.06.029. Epub 2020 Jul 7.

本文引用的文献

Double Umbilical Cord Blood Transplantation in High-Risk Hematological Patients: A Phase II Study Focusing on the Mechanism of Graft Predominance.

Hemasphere. 2019 Aug 9;3(4):e285. doi: 10.1097/HS9.0000000000000285. eCollection 2019 Oct.

How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide.

Blood. 2019 Nov 21;134(21):1802-1810. doi: 10.1182/blood.2019001323.

Immune reconstitution after T-cell replete HLA-haploidentical transplantation.

Semin Hematol. 2019 Jul;56(3):221-226. doi: 10.1053/j.seminhematol.2019.03.005. Epub 2019 Mar 26.

NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.

Blood. 2018 Jan 11;131(2):247-262. doi: 10.1182/blood-2017-05-780668. Epub 2017 Oct 6.

Dendritic Cell Recovery Impacts Outcomes after Umbilical Cord Blood and Sibling Donor Transplantation for Hematologic Malignancies.

Biol Blood Marrow Transplant. 2017 Nov;23(11):1925-1931. doi: 10.1016/j.bbmt.2017.07.008. Epub 2017 Jul 17.

Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide.

J Clin Oncol. 2017 Sep 10;35(26):3002-3009. doi: 10.1200/JCO.2017.72.8428. Epub 2017 Jun 23.

CD4+ T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation.

Blood. 2016 Oct 27;128(17):2165-2174. doi: 10.1182/blood-2016-06-718619. Epub 2016 Aug 16.

Early evaluation of immune reconstitution following allogeneic CD3/CD19-depleted grafts from alternative donors in childhood acute leukemia.

Bone Marrow Transplant. 2012 Nov;47(11):1419-27. doi: 10.1038/bmt.2012.43. Epub 2012 Mar 12.

High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation.

Immunol Res. 2010 Jul;47(1-3):65-77. doi: 10.1007/s12026-009-8139-0.

Hematopoietic stem-cell transplantation.

N Engl J Med. 2006 Apr 27;354(17):1813-26. doi: 10.1056/NEJMra052638.

CD4+ T-cell alloreactivity after haploidentical hematopoietic stem cell transplantation.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

CD4+ T-cell alloreactivity after haploidentical hematopoietic stem cell transplantation.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献